Florida Allergy Asthma & Immunology Society Inc is a 501(c)(6) organization based in Jacksonville, Florida, registered in 1996, with $601,379 in FY2024 revenue. CharityIndex grades it C+.
Revenue (FY2024)
$601K
▲ 62.3% vs prior year
Expenses (FY2024)
$486K
Net assets
$995K
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Florida Allergy Asthma & Immunology Society Inc— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Florida Allergy Asthma & Immunology Society Inc: 25 mo reserves · +19% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Florida Allergy Asthma & Immunology Society Inc— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Florida Allergy Asthma & Immunology Society Inc: 1 of 5 disclosure signals earns a D on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $290K (FY2013) to $601K (FY2024) across 12 reported years.
Financial snapshot
Operating margin
19.2%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$995K
Total liabilities
$0
Net assets
$995K
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $601,379▲62.3% | $485,811▲21.1% | $994,686▲13.1% | $994,686▲13.1% | 990 |
| 2023 | $370,426▼5.0% | $401,113▲62.9% | $879,118▼3.4% | $879,118▼3.4% | 990 |
| 2022 | $390,102▲8.2% | $246,235▼28.7% | $909,805▲19.1% | $909,805▲19.1% | 990 |
| 2021 | $360,671▲136% | $345,157▲136% | $764,144▼4.7% | $764,144▼4.7% | 990 |
| 2020 | $153,065▼58.7% | $146,269▼49.3% | $801,422▲3.0% | $801,422▲3.0% | 990 |
| 2019 | $370,363▲47.7% | $288,499▼3.0% | $777,939▲11.3% | $777,939▲11.3% | 990 |
| 2018 | $250,788▼9.0% | $297,512▲30.5% | $699,076▼6.3% | $699,076▼6.3% | 990 |
| 2017 | $275,653▼13.2% | $227,899▼13.3% | $745,798▲7.0% | $745,798▲7.0% | 990 |
| 2016 | $317,526▲7.7% | $262,884▲29.4% | $696,920▲8.4% | $696,920▲8.4% | 990 |
| 2015 | $294,796▲23.6% | $203,173▲4.6% | $642,791▲16.8% | $642,791▲16.8% | 990 |
| 2014 | $238,536▼17.7% | $194,176▼14.8% | $550,367▲8.8% | $550,367▲8.8% | 990 |
| 2013 | $289,689 | $227,876▲6.8% | $506,005▲13.9% | $506,005▲13.9% | 990 |
| 2012 | — | $213,364▲15.2% | $444,192▲10.5% | $444,192▲10.5% | 990 |
| 2011 | — | $185,145▼12.8% | $402,055▲30.6% | $402,055▲30.6% | 990 |
| 2010 | — | $212,302 | $307,844 | $307,844 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for Florida Allergy Asthma & Immunology Society Inc (EIN 59-3374796) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.